Taysha Gene Therapies, Inc. (TSHA) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $2.50M2023: $15.45M2024: $8.33M2025: $9.77M$9.77M
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$9.77M+17.3%
2024$8.33M-46.1%
2023$15.45M+517.5%
2022$2.50M